You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Early Release Article, posted November 13, 2006
  JAMA
  •  Online Features
  Editorial
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Challenges for Improving Medication Adherence

Ross J. Simpson, Jr, MD, PhD

JAMA. 2006;296:(doi:10.1001/jama.296.21.jed60074).

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

For chronic medical conditions, such as hypercholesterolemia and hypertension, a wide and persistent separation exists between evidence-based recommendations and the actual care patients receive.1 Reasons for this gap are not always clear, but some components are obvious, including failing to identify patients in need of treatment, not properly initiating treatment, failing to provide proper drugs at proper doses, and neglecting to involve the patient in the choices inherent in care. Lack of persistence with adherence to prescribed treatments is a critical part of the gap.2 A sustained high level of adherence identifies a pattern of healthy behaviors3-4 and allows medications shown to be effective in clinical trials to improve outcomes, but this is difficult to achieve with many chronic conditions. For instance, adherence rates to cholesterol-lowering drugs or antihypertension medications are poor.5-8

Despite its importance, adherence to therapy is an individual patient behavior that . . . [Full Text of this Article]

Author Affiliation: Department of Medicine, University of North Carolina at Chapel Hill.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

Effect of a Pharmacy Care Program on Medication Adherence and Persistence, Blood Pressure, and Low-Density Lipoprotein Cholesterol: A Randomized Controlled Trial
Jeannie K. Lee, Karen A. Grace, and Allen J. Taylor
JAMA. 2006;296(21):2563-2571.
ABSTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Determinants of non-adherence to subsidized anti-retroviral treatment in southeast Nigeria
Uzochukwu et al.
Health Policy Plan 2009;24:189-196.
ABSTRACT | FULL TEXT  

Improving Medication Adherence in Chronic Cardiovascular Disease
Albert
Crit Care Nurse 2008;28:54-64.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2006 American Medical Association. All Rights Reserved.